<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02656836</url>
  </required_header>
  <id_info>
    <org_study_id>REC 15/EM/0217</org_study_id>
    <nct_id>NCT02656836</nct_id>
  </id_info>
  <brief_title>Home Tonometry With the I-care Tonometer for Glaucoma</brief_title>
  <official_title>Home Tonometry for Monitoring Glaucoma:a Pilot Study of the Icare Home Tonometer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Queen's University, Belfast</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Belfast Health and Social Care Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Queen's University, Belfast</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objective of the study is to scope the self-management for self-monitoring
      glaucoma using home tonometry.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Monitoring of glaucoma requires frequent evaluation of IOP and disease severity, typically
      with visual field tests. When a patient is diagnosed with glaucoma an optimum level of IOP
      (or target IOP) is determined based on patient's characteristics, such as severity of disease
      and life expectancy. In current models of care patients have their IOP measured at the clinic
      at different intervals. If the IOP is noted to be high, or above the patient's target,
      additional treatment is recommended. Accurate and frequent IOP measurements at different
      points in time are thus imperative.

      Tonometry is usually conducted by clinicians in an eye clinic. Some tonometers (e.g., Icare)
      have the potential to be used by the individual for home monitoring of IOP for patients with
      suspected glaucoma/glaucoma. Self-monitoring of IOP via home tonometry will allow patients to
      undergo IOP measurements at different points in time (e.g., early morning and night-time, and
      it can help determine diurnal changes and spikes).

      The overall objective of the current study is to conduct a feasibility pilot study on the
      home tonometer (Icare), acquiring initial experience with the Icare tonometer. For this
      purpose investigators will train up to 20 individuals on how to use the device. Investigators
      will ask them to record in a diary their IOP twice a day for a period of 2 weeks.
      Investigators will then compare IOP outcomes with the measurement taken at the clinic.
      Patients and clinicians will be masked to the IOP data.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Intraocular Pressure</measure>
    <time_frame>Two weeks</time_frame>
    <description>Intraocular pressure in mmHg units, obtained by tonometers. The investigators will determine agreement of intraocular pressure (IOP) measured using the home tonometer (patient) compared with IOP measured in the clinic.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of Patients Able and Willing to Use the Tonometer</measure>
    <time_frame>Two weeks</time_frame>
    <description>Proportion of patients willing to use the tonometer but are unable to. Patient feedback reported via questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of Patients With an Adverse Event</measure>
    <time_frame>One month</time_frame>
    <description>Any adverse event or complication associated with the use of the device. Expected side effects will be corneal erosion, and ocular irritation.</description>
  </secondary_outcome>
  <enrollment type="Actual">20</enrollment>
  <condition>Glaucoma</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Home tonometry, diagnostic study</intervention_name>
    <description>Evaluating intraocular pressure</description>
    <other_name>I-care tonometer</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adults with glaucoma attending clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Attending the glaucoma clinic for monitoring (for glaucoma or ocular hypertension)

          2. Aged 18 years or over

          3. Patient deemed able to monitor their IOP at home (by themselves or a helper)

        Exclusion Criteria:

          1. Not receiving IOP monitoring (for glaucoma or ocular hypertension)

          2. Aged &lt;18 years

          3. Patients deemed unable to monitor their IOP at home (and do not have someone who can
             help them) e.g., apparent physical or cognitive impairments that will not allow for
             the use of a home tonometer

          4. Had surgery for their glaucoma (glaucoma surgery onlyÍ¾ other surgeries included e.g.,
             cataract surgery)

          5. Patient has preexisting corneal disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Augusto Azuara-Blanco</last_name>
    <role>Principal Investigator</role>
    <affiliation>Queen's University, Belfast</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre for Experimental Medicine QUB</name>
      <address>
        <city>Belfast</city>
        <state>Co.Antrim</state>
        <zip>BT12 6BA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 11, 2016</study_first_submitted>
  <study_first_submitted_qc>January 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 15, 2016</study_first_posted>
  <results_first_submitted>January 9, 2020</results_first_submitted>
  <results_first_submitted_qc>January 27, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">February 5, 2020</results_first_posted>
  <last_update_submitted>January 27, 2020</last_update_submitted>
  <last_update_submitted_qc>January 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Queen's University, Belfast</investigator_affiliation>
    <investigator_full_name>Professor Augusto Azuara-Blanco</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Could not recruit target number of participants within the time frame</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Home Tonometry Group</title>
          <description>No comparator</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Home Tonometry Group</title>
          <description>No comparator</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="6"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Intraocular Pressure</title>
        <description>Intraocular pressure in mmHg units, obtained by tonometers. The investigators will determine agreement of intraocular pressure (IOP) measured using the home tonometer (patient) compared with IOP measured in the clinic.</description>
        <time_frame>Two weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Home Tonometry Group</title>
          </group>
        </group_list>
        <measure>
          <title>Intraocular Pressure</title>
          <description>Intraocular pressure in mmHg units, obtained by tonometers. The investigators will determine agreement of intraocular pressure (IOP) measured using the home tonometer (patient) compared with IOP measured in the clinic.</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.85" spread="3.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Proportion of Patients Able and Willing to Use the Tonometer</title>
        <description>Proportion of patients willing to use the tonometer but are unable to. Patient feedback reported via questionnaire</description>
        <time_frame>Two weeks</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Proportion of Patients With an Adverse Event</title>
        <description>Any adverse event or complication associated with the use of the device. Expected side effects will be corneal erosion, and ocular irritation.</description>
        <time_frame>One month</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Home Tonometry Group</title>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Augusto Azuara-Blanco</name_or_title>
      <organization>Queen's University Belfast</organization>
      <phone>2890976350</phone>
      <email>a.azuara-blanco@qub.ac.uk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

